Byron Olsen

Byron Olsen currently serves as the Head of Legal Affairs and Vice President of Intellectual Property at e-therapeutics PLC, focusing on the revitalization of legal and corporate risk management functions through the application of AI technology, achieving a 33% reduction in external legal costs. Previously, at Absci, Olsen established the company's first in-house patent department and integrated advanced antibody engineering innovations into the global IP portfolio. Other notable roles include Deputy General Counsel at Dicerna Pharmaceuticals and Chief Patent Counsel at CONAGEN, where leadership in USPTO litigation and EPO oppositions was prominent. Olsen's legal expertise was further developed during a decade-long tenure at Monsanto. Educational background includes a Bachelor of Science in Genetics from the University of California, Davis, and a Juris Doctor in Law/Intellectual Property Law from Albany Law School.